| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Letrozole | Letrozole Diacid Impurity | VL2730003 | View CAS 1644566-39-1 |
| Letrozole | Letrozole EP Impurity B | VL2730004 | View CAS 113402-31-6 |
| Letrozole | Letrozole N-Oxide | VL2730001 | View |
| Letrozole | Letrozole Related Compound A | VL2730002 | View CAS 112809-52-6 |
| Catalogue No. | VL2730002 |
| CAS No. | 112809-52-6 |
| Molecular Formula | C₁₇H₁₁N₅ |
| Molecular Weight | 285.3 |
| Parent drug | Letrozole |
| IUPAC Name | 4, 4'-(4H-1, 2, 4-Triazol-4-ylmethylene)bisbenzonitrile |
| Synonyms | N/A |
| References | Sci-Hub, Metabolomics Reveals that Dietary Xenoestrogens Alter Cellular Metabolism Induced by Palbociclib/Letrozole Combination Cancer Therapy, 10.1016/j.chembiol.2017.12.010. (2017). Retrieved December 15, 2021, from Hkvisa.net website: https://sci-hub.hkvisa.net/10.1016/j.chembiol.2017.12.010 |
| Status | In-stock |
| ListName | Letrozole Related Compound A |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
